Literature DB >> 26229086

Circulating miR-33a and miR-33b are up-regulated in familial hypercholesterolaemia in paediatric age.

Francesco Martino1, Fabrizio Carlomosti2, Daniele Avitabile3, Luca Persico4, Mario Picozza2, Francesco Barillà5, Marcello Arca6, Anna Montali6, Eliana Martino7, Cristina Zanoni7, Sandro Parrotto8, Alessandra Magenta9.   

Abstract

Hypercholesterolaemia is one of the major causes of CVD (cardiovascular disease). It is associated with enhanced oxidative stress, leading to increased lipid peroxidation which in turn determines endothelial dysfunction and susceptibility to coronary vasoconstriction and atherosclerosis. Different miRNAs are involved in the pathogenesis of CVD and play an important role in inflammatory process control, therefore, together with atherogenic factors, they can stimulate atherosclerotic degeneration of the vessel walls of arteries. miR-33a and miR-33b play a pivotal role in a variety of biological processes including cholesterol homoeostasis, HDL (high-density lipoprotein)-cholesterol formation, fatty acid oxidation and insulin signalling. Our study aimed to determine whether circulating miR-33a and miR-33b expression was altered in familial hypercholesterolaemic children. Total RNA was extracted from plasma, and miR-33a and miR-33b were measured by quantitative real-time PCR. We found that miR-33a and miR-33b were significantly up-regulated in the plasma of 28 hypercholesterolaemic children compared with 25 healthy subjects (4.49±0.27-fold increase, P<0.001, and 3.21±0.39-fold increase, P<0.05 respectively), and for both miRNAs, a positive correlation with total cholesterol, LDL (low-density lipoprotein)-cholesterol, LDL-cholesterol/HDL-cholesterol ratio, apolipoprotein B, CRP (C-reactive protein) and glycaemia was found. OLS (ordinary least squares) regression analysis revealed that miR-33a was significantly affected by the presence of FH (familial hypercholesterolaemia), glycaemia and CRP (P<0.001, P<0.05 and P<0.05 respectively). The same analysis showed that miR-33b was significantly related to FH and CRP (P<0.05 and P<0.05 respectively). Although it is only explorative, the present study could be the first to point to the use of miR-33a and miR-33b as early biomarkers for cholesterol levels in childhood, once validated in independent larger cohorts.
© 2015 Authors; published by Portland Press Limited.

Entities:  

Keywords:  cardiovascular disease; hypercholesterolaemia; lipoproteins; miR-33; miRNAs; paediatrics

Mesh:

Substances:

Year:  2015        PMID: 26229086     DOI: 10.1042/CS20150235

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  21 in total

Review 1.  Role of miRNAs in human disease and inborn errors of metabolism.

Authors:  Ana Rivera-Barahona; Belén Pérez; Eva Richard; Lourdes R Desviat
Journal:  J Inherit Metab Dis       Date:  2017-02-22       Impact factor: 4.982

2.  Human MiR-4660 regulates the expression of alanine-glyoxylate aminotransferase and may be a biomarker for idiopathic oxalosis.

Authors:  Xin Tu; Yuanyuan Zhao; Qianqian Li; Xiao Yu; Yang Yang; Shumei Shi; Zuochuan Ding; Yan Miao; Zhimiao Zou; Xinqiang Wang; Jipin Jiang; Dunfeng Du
Journal:  Clin Exp Nephrol       Date:  2019-03-09       Impact factor: 2.801

3.  Epigenetic Hallmarks of Fetal Early Atherosclerotic Lesions in Humans.

Authors:  Filomena de Nigris; Francesco Cacciatore; Francesco P Mancini; Dino F Vitale; Gelsomina Mansueto; Francesco P D'Armiento; Concetta Schiano; Andrea Soricelli; Claudio Napoli
Journal:  JAMA Cardiol       Date:  2018-12-01       Impact factor: 14.676

Review 4.  miRNAs and High-Density Lipoprotein metabolism.

Authors:  Ángel Baldán; Thomas Q de Aguiar Vallim
Journal:  Biochim Biophys Acta       Date:  2016-02-09

5.  Induction of MiR133a expression by IL-19 targets LDLRAP1 and reduces oxLDL uptake in VSMC.

Authors:  Khatuna Gabunia; Allison B Herman; Mitali Ray; Sheri E Kelemen; Ross N England; Raul DeLa Cadena; William J Foster; Katherine J Elliott; Satoru Eguchi; Michael V Autieri
Journal:  J Mol Cell Cardiol       Date:  2017-02-28       Impact factor: 5.000

Review 6.  The Prospective Application of Melatonin in Treating Epigenetic Dysfunctional Diseases.

Authors:  Seth Mikaye Monayo; Xin Liu
Journal:  Front Pharmacol       Date:  2022-05-20       Impact factor: 5.988

Review 7.  The Role of MicroRNAs in Hyperlipidemia: From Pathogenesis to Therapeutical Application.

Authors:  Yu Xiang; Li Mao; Mei-Ling Zuo; Gui-Lin Song; Li-Ming Tan; Zhong-Bao Yang
Journal:  Mediators Inflamm       Date:  2022-06-17       Impact factor: 4.529

Review 8.  Truths and controversies concerning the role of miRNAs in atherosclerosis and lipid metabolism.

Authors:  Ángel Baldán; Carlos Fernández-Hernando
Journal:  Curr Opin Lipidol       Date:  2016-12       Impact factor: 4.776

9.  Extracellular Nucleophosmin Is Increased in Psoriasis and Correlates With the Determinants of Cardiovascular Diseases.

Authors:  Marco D'Agostino; Sara Beji; Sara Sileno; Daniela Lulli; Laura Mercurio; Stefania Madonna; Corrado Cirielli; Sabatino Pallotta; Cristina Albanesi; Maurizio C Capogrossi; Daniele Avitabile; Guido Melillo; Alessandra Magenta
Journal:  Front Cardiovasc Med       Date:  2022-04-28

Review 10.  microRNAs involved in psoriasis and cardiovascular diseases.

Authors:  Sara Sileno; Sara Beji; Marco D'Agostino; Alessandra Carassiti; Guido Melillo; Alessandra Magenta
Journal:  Vasc Biol       Date:  2021-06-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.